Graphite Bio Inc
NASDAQ:GRPH 4:00:00 PM EDT
Graphite Bio Inc Stock, NASDAQ:GRPH
611 Gateway Boulevard, Suite 120, South San Francisco, California 94080
United States of America
Phone: +1.650.484.0886
Number of Employees: 6
Description
Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA.